439 related articles for article (PubMed ID: 11395408)
21. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
22. PTEN: a newly identified regulator of neuronal differentiation.
Ross AH; Lachyankar MB; Recht LD
Neuroscientist; 2001 Aug; 7(4):278-81. PubMed ID: 11488393
[TBL] [Abstract][Full Text] [Related]
23. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
[TBL] [Abstract][Full Text] [Related]
25. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
26. Pten is essential for embryonic development and tumour suppression.
Di Cristofano A; Pesce B; Cordon-Cardo C; Pandolfi PP
Nat Genet; 1998 Aug; 19(4):348-55. PubMed ID: 9697695
[TBL] [Abstract][Full Text] [Related]
27. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
Tamura M; Gu J; Takino T; Yamada KM
Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
[TBL] [Abstract][Full Text] [Related]
28. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
30. Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
Rouault JP; Kuwabara PE; Sinilnikova OM; Duret L; Thierry-Mieg D; Billaud M
Curr Biol; 1999 Mar; 9(6):329-32. PubMed ID: 10209098
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
Yamada KM; Araki M
J Cell Sci; 2001 Jul; 114(Pt 13):2375-82. PubMed ID: 11559746
[TBL] [Abstract][Full Text] [Related]
32. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
33. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells.
Nielsen-Preiss SM; Silva SR; Gillette JM
J Cell Biochem; 2003 Dec; 90(5):964-75. PubMed ID: 14624456
[TBL] [Abstract][Full Text] [Related]
34. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
35. Conserved synteny between the Fugu and human PTEN locus and the evolutionary conservation of vertebrate PTEN function.
Yu WP; Pallen CJ; Tay A; Jirik FR; Brenner S; Tan YH; Venkatesh B
Oncogene; 2001 Sep; 20(39):5554-61. PubMed ID: 11571655
[TBL] [Abstract][Full Text] [Related]
36. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
37. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
Oudit GY; Sun H; Kerfant BG; Crackower MA; Penninger JM; Backx PH
J Mol Cell Cardiol; 2004 Aug; 37(2):449-71. PubMed ID: 15276015
[TBL] [Abstract][Full Text] [Related]
38. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells.
Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB
Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304
[TBL] [Abstract][Full Text] [Related]
39. PTEN gene and integrin signaling in cancer.
Tamura M; Gu J; Tran H; Yamada KM
J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
[TBL] [Abstract][Full Text] [Related]
40. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]